Emergent BioSolutions Inc. SEC filings EBS
Emergent BioSolutions Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 29, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 15, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | Mar 24, 2025 | — |
| POS EX | Filing | Mar 4, 2025 | — |
| EFFECT | Filing | Dec 4, 2024 | — |
| CORRESP | Letter to the SEC | Dec 2, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2024 | — |
| NT 10-Q | Filing | Nov 9, 2023 | Sep 30, 2023 |
| DEFR14A | Filing | Apr 24, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2021 | — |
| CORRESP | Letter to the SEC | Nov 12, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CORRESP | Letter to the SEC | Sep 30, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 16, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 19, 2021 | — |
| CT ORDER | Filing | Mar 22, 2019 | — |
| CT ORDER | Filing | Mar 20, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2019 | — |
| CT ORDER | Filing | Feb 27, 2019 | — |
| CORRESP | Letter to the SEC | Jan 11, 2019 | — |
| CORRESP | Letter to the SEC | Dec 17, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2018 | — |
| CT ORDER | Filing | Nov 27, 2018 | — |
| CT ORDER | Filing | Nov 13, 2018 | — |
| CT ORDER | Filing | Nov 13, 2018 | — |
| D | Filing | Oct 30, 2018 | — |
| CT ORDER | Filing | Sep 4, 2018 | — |
| CT ORDER | Filing | Jun 12, 2018 | — |
| CT ORDER | Filing | Apr 3, 2018 | — |
| CT ORDER | Filing | Dec 7, 2017 | — |
| CT ORDER | Filing | Aug 14, 2017 | — |
| CT ORDER | Filing | Aug 14, 2017 | — |
| CT ORDER | Filing | May 15, 2017 | — |
| CT ORDER | Filing | Mar 31, 2017 | — |
| CT ORDER | Filing | Feb 28, 2017 | — |
| CT ORDER | Filing | Feb 14, 2017 | — |
| CT ORDER | Filing | Dec 23, 2016 | — |
| CT ORDER | Filing | Dec 15, 2016 | — |
| CT ORDER | Filing | Dec 15, 2016 | — |
| CT ORDER | Filing | Dec 15, 2016 | — |
| CT ORDER | Filing | Dec 15, 2016 | — |
| CT ORDER | Filing | Dec 15, 2016 | — |
| CT ORDER | Filing | Dec 2, 2016 | — |
| CT ORDER | Filing | Dec 2, 2016 | — |
| CT ORDER | Filing | Nov 15, 2016 | — |
| CT ORDER | Filing | Nov 15, 2016 | — |
| CT ORDER | Filing | Aug 17, 2016 | — |
| CT ORDER | Filing | Aug 17, 2016 | — |
| CT ORDER | Filing | May 6, 2016 | — |
| CT ORDER | Filing | May 6, 2016 | — |
| CT ORDER | Filing | May 6, 2016 | — |
| CT ORDER | Filing | May 6, 2016 | — |
| CT ORDER | Filing | Jan 21, 2016 | — |
| CT ORDER | Filing | Dec 17, 2015 | — |
| CT ORDER | Filing | Apr 30, 2015 | — |
| CT ORDER | Filing | Feb 9, 2015 | — |
| CT ORDER | Filing | Jan 28, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2015 | — |
| CORRESP | Letter to the SEC | Jan 15, 2015 | — |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EBS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Accelerated filer
- SEC CIK
- 1367644
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.